 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 1537 | 回復: 4 | |||
xuzhwei木蟲 (小有名氣)
|
[求助]
急，藥品說明書翻譯
|
|
【不良反應】 1、少數患者用藥后出現惡心、泛酸、腹痛、腹瀉、大便干、腹脹、胃部不適、胃部脹滿、胸悶不適，心悸，尿痛等癥狀。 2、少數患者用藥后出現ALT、BUN、Scr輕度升高 3、個別患者用藥后出現尿紅細胞、尿蛋白、尿糖陽性、大便檢查有紅細胞。 4、個別患者用藥后出現頻發(fā)早搏等。 【禁忌】嚴重胃炎、胃及十二指腸潰瘍者禁用。 【注意事項】 1、 個別患者用藥后可出現血小板升高或者降低，但無法判斷是否與藥物有關。 2、 肝功能不全者慎用 3、 臨床用藥期間定期檢查肝腎（ALT、BUN、Scr）功能及血、尿、大便常規(guī)。 4、 現有的安全性是本品是以42天的安全性結果，不宜超療程使用。 【臨床試驗】本品于2000年3月由國家食品藥品監(jiān)督管理局批準臨床研究，于2001年11月至2005年3月進行了Ⅱ、Ⅲ期臨床試驗。臨床試驗采用平行對照、區(qū)組隨機、雙盲單模擬、多中心試驗設計方法，觀察了黃莪膠囊用于良性前列腺增生癥氣虛血瘀、濕熱阻滯證的有效性和安全性，對照藥為癃閉舒膠囊。Ⅱ期臨床試驗的總病例數為220例，黃莪膠囊組116例，癃閉舒膠囊組104例；Ⅲ期臨床試驗的總病例數485例，其中黃莪膠囊組323例，癃閉舒膠囊組162例。觀察療程為42天。主要療效性觀察指標為良性前列腺增生癥相關癥狀、體征，國際前列腺癥狀評分（I-PSS）尿流率和殘余尿量等。 試驗結果顯示：Ⅱ、Ⅲ期臨床試驗的療效，I-PSS總分療效的比較，兩組積分變化差異無統(tǒng)計學意義，尿流率變化兩組差異無統(tǒng)計學意義，兩組治療前后積分改善比較，組間比較差異無統(tǒng)計學意義。殘余尿量、B超前列腺大小變化、癥狀積分的大小、不同時點排尿不禁感記分變化的統(tǒng)計學比較，兩組生活質量指數的變化比較，兩組差異無統(tǒng)計學意義。 2009年9月-2010年4月補充了74對（試驗組和安慰劑對照組各74例）隨機、雙盲、安慰劑對照的多中心臨床試驗，療程為42天，重點觀察本品對良性前列腺增生癥氣虛血瘀、濕熱阻滯證的中醫(yī)證候療效以及相應的安全性。結果顯示本品對中醫(yī)證候總有效率優(yōu)于安慰劑對照組，對疾病的綜合療效試驗組優(yōu)于安慰劑對照組。 黃莪膠囊組經過約500例治療前后的血、尿、大便常規(guī)、肝功能（ALT）、腎功能（BUN、Scr），Ⅱ、Ⅲ期臨床試驗中，有8例肝功能（ALT）治療前正常治療后異常升高（56-141U/L），1例治療前異常治療后異常加重，均認為可能與藥物有關；出現腎功能（BUN、Scr）相關指標治療前正常治療后異常升高者，有3例認為可能與藥物有關，3例與藥物的關系認為可疑；個別患者服用后出現尿紅細胞，尿蛋白輕度異常，尿糖陽性、大便檢查出現紅細胞、血小板升高或降低，該類不良事件多數為與藥物可能有關、可疑、無法判斷。臨床試驗期間，少數患者服藥后出現惡心、泛酸、腹痛、腹瀉、大便干、腹脹、胃部不適、胃部脹滿、胸悶不適，心悸，尿痛，多數判斷與藥物有關或可能有關，1例患者有早搏病史，用藥后出現頻發(fā)早搏，患者退出試驗，認為與藥物的關系可疑，轉歸為癥狀消失后無后遺癥，1例患者用藥后出現房顫，研究者認為與藥物無關。 【藥理毒理】非臨床藥效學試驗結果顯示：本品能縮小去勢加皮下注射丙酸睪丸素大鼠模型的前列腺體積，降低前列腺濕重和干重，縮小平均腺腔，減少腺腔中蛋白物質含量；能縮小良性前列腺增生老年犬的前列腺體積，降低前列腺組織中RNA和DNA的含量，增加腺小葉數；能抑制去甲腎上腺素所致小鼠腸系膜微血管的收縮。 |
回復此樓» 收錄本帖的淘帖專輯推薦
 精品翻譯集錦 |
» 猜你喜歡
284求調劑
已經有3人回復
-
085601一志愿中山大學深圳材料工程330求調劑
已經有3人回復
-
一志愿北化085600材料專碩275|有文章專利｜求調劑
已經有12人回復
-
材料專業(yè)申博
已經有4人回復
-
311求調劑一志愿合肥工業(yè)大學
已經有5人回復
-
070300化學279求調劑
已經有6人回復
-
材料與化工（0856）304求B區(qū)調劑
已經有9人回復
-
085601 329分調劑
已經有3人回復
-
本2一志愿C9-333分，材料科學與工程，求調劑
已經有3人回復
-
一志愿大連理工大學材料求調劑
已經有5人回復
xuzhwei
木蟲 (小有名氣)
- 應助: 0 (幼兒園)
- 金幣: 1872.5
- 散金: 30
- 紅花: 1
- 帖子: 193
- 在線: 173.4小時
- 蟲號: 310305
- 注冊: 2006-12-24
- 性別: GG
- 專業(yè): 中藥學其他科學問題
2樓2012-07-10 14:29:17
linchenyu
鐵蟲 (小有名氣)
- 應助: 9 (幼兒園)
- 金幣: 864.3
- 帖子: 65
- 在線: 78.6小時
- 蟲號: 1578292
- 注冊: 2012-01-15
- 性別: MM
- 專業(yè): 腫瘤研究體系新技術
【答案】應助回帖
★ ★ ★ ★ ★
sltmac: 金幣-5, 違規(guī)存檔, google翻譯，初犯，扣5金幣予以警告 2012-08-12 08:05:51
sltmac: 金幣-5, 違規(guī)存檔, google翻譯，初犯，扣5金幣予以警告 2012-08-12 08:05:51
|
Adverse reactions A small number of patients after treatment of nausea, pantothenic acid, abdominal pain, diarrhea, dry stools, bloating, stomach discomfort, stomach fullness, chest discomfort, palpitations, dysuria and other symptoms. 2, a small number of patients after administration of ALT, BUN and Scr mild increase Individual patients after treatment, urine red blood cells, urine protein and urine sugar positive stool examination red blood cells. Individual patients after treatment, frequent premature beats and so on. Taboo severe gastritis, gastric and duodenal ulcers disabled. [Note] Individual patients after treatment, there may be platelet increase or decrease, but can not determine whether drug-related. 2, liver dysfunction, caution 3, during the clinical use of drugs on a regular basis to check liver and kidney (ALT, BUN, Scr in) function and blood, urine, stool. 4, the safety of this product is 42 days of the security results, not ultra-treatment. Clinical trials this product in March 2000 by the State Food and Drug Administration approved clinical studies in November 2001 to March 2005, II, Ⅲ clinical trials. Clinical trials using parallel control block randomized, double-blind, single analog, multi-center trial design method to observe the yellow Curcuma capsules for benign prostatic hyperplasia blood stasis, damp heat of the efficacy and safety of the block permit, control drug for the Rongbishu capsule. Phase II clinical trial of the total number of cases to 220 cases of yellow the Curcuma capsule group 116 cases, Longbitong Capsule 104 cases; Phase III clinical trials, the total number of cases 485 cases, of which Huang Curcuma capsules group of 323 cases Longbitong Capsule group of 162 cases. The observed treatment for 42 days. The primary efficacy outcome measure was benign prostatic hyperplasia-related symptoms, signs, international prostate symptom score (I-PSS) and urinary flow rate and residual urine volume. The test results showed that: II, III clinical trial of the efficacy of the I-PSS score efficacy comparison of two sets of points difference in not statistically significant, urinary flow rate changes in two groups no significant difference between two groups before and after treatment points to improve The comparison between the two groups was no significant difference. Residual urine volume, B ultra prostate size changes, the size of the symptom score different points in time urination can not help but sense the scoring change was statistically compared the two sets of quality of life index change, the difference was not statistically significant. Supplemented in September 2009 -2010 April 74 pairs (test group and the placebo control group, n = 74) randomized, double-blind, placebo-controlled multi-center clinical trials, treatment for 42 days, focusing on observation of the goods on the benign prostatic hyperplasia blood stasis, heat block permits TCM syndromes efficacy and safety of The results show that the goods on the TCM syndromes and there is always more efficient than the placebo control group, disease efficacy trial group than the placebo control group. Huang Curcuma capsules group of about 500 cases before and after treatment the blood, urine, stool, liver function (ALT), renal function (BUN and Scr), II, III of clinical trials, 8 cases of liver function (ALT) before treatment abnormal elevation of normal after treatment (56-141U / L), abnormal pre-treatment abnormal treatment increase the view that may be drug-related; related indicators of renal function (BUN and Scr) before treatment for the treatment of abnormal elevation of three cases may be drug-related, and three cases with drugs considered suspicious; individual patients after taking the red blood cells in urine, urine protein was abnormal, positive urine, stool check red blood cells, platelets increase or decrease such The majority of adverse events with drugs that may be related, suspicious, can not determine. During clinical trials, a few patients after taking the nausea, pantothenic acid, abdominal pain, diarrhea, dry stools, bloating, stomach discomfort, stomach fullness, chest discomfort, palpitations, dysuria, the majority judgment, and drug or might be relevant, patients with premature history of frequent premature beats after treatment, the patient withdrew from the study that a suspicious relationship with the drug, and outcome of symptoms without sequelae and one patient after treatment, atrial fibrillation, the researchers believe has nothing to do with drug. Pharmacological effects of non-clinical pharmacodynamic trial results showed that: This product can reduce the castration plus subcutaneous injection of propionate testosterone rat model of prostate volume, reduce prostate wet weight and dry weight, reduce the average glandular reduce the glandular The content of protein substances; narrowing of older dogs with benign prostatic hyperplasia, prostate volume, reduce prostate tissue RNA and DNA content, and increase the number of glandular lobules; can inhibit norepinephrine-induced contraction of mouse mesenteric microvessels. |
3樓2012-07-13 19:12:50
linchenyu
鐵蟲 (小有名氣)
- 應助: 9 (幼兒園)
- 金幣: 864.3
- 帖子: 65
- 在線: 78.6小時
- 蟲號: 1578292
- 注冊: 2012-01-15
- 性別: MM
- 專業(yè): 腫瘤研究體系新技術
4樓2012-07-13 19:14:54
xuzhwei
木蟲 (小有名氣)
- 應助: 0 (幼兒園)
- 金幣: 1872.5
- 散金: 30
- 紅花: 1
- 帖子: 193
- 在線: 173.4小時
- 蟲號: 310305
- 注冊: 2006-12-24
- 性別: GG
- 專業(yè): 中藥學其他科學問題
5樓2012-07-14 21:20:25
相關版塊跳轉
我要訂閱樓主 xuzhwei 的主題更新
| 5 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 本科211總分289，08工學真心求調劑 +3 | utopiaE 2026-03-30 | 3/150 |
|
|---|---|---|---|---|
|
|
[考研] 一志愿中海洋材料357 +3 | 麥恩莉. 2026-03-30 | 3/150 |
|
|
|
[考研] 一志愿華中師范化學332分求調劑 +3 | Lyy930824@ 2026-03-29 | 3/150 |
|
|
|
[考研] 085600 286分 材料求調劑 +11 | 麻辣魷魚 2026-03-27 | 12/600 |
|
|
|
[考研] 26考研-291分-廈門大學（085601）-柔性電子學院材料工程專業(yè)求調劑 +5 | min3 2026-03-24 | 6/300 |
|
|
|
[考研] 化學0703 調劑 306分 一志愿211 +8 | 26要上岸 2026-03-28 | 8/400 |
|
|
[考研] 317求調劑 +10 | 蛋黃咸肉粽 2026-03-26 | 10/500 |
|
|
|
[考研] 311求調劑 +6 | 冬十三 2026-03-24 | 6/300 |
|
|
|
[考研] 349求調劑 +6 | 李木子啊哈哈 2026-03-25 | 6/300 |
|
|
|
[考研] 330分求調劑 +5 | qzenlc 2026-03-29 | 5/250 |
|
|
|
[考研] 071000生物學求調劑，初試成績343 +7 | 小小甜面團 2026-03-25 | 7/350 |
|
|
|
[考研] 復試調劑 +3 | raojunqi0129 2026-03-28 | 3/150 |
|
|
|
[考研] 339求調劑，想調回江蘇 +6 | 烤麥芽 2026-03-27 | 8/400 |
|
|
|
[考研] 0856調劑 +5 | 求求讓我有書讀?/a> 2026-03-26 | 6/300 |
|
|
|
[考研] 085601 材料工程 313分 求調劑 +5 | Ong3 2026-03-27 | 5/250 |
|
|
|
[考研] 0703化學一志愿南京師范大學303求調劑 +3 | zzffylgg 2026-03-24 | 3/150 |
|
|
|
[考研] 總分322求生物學/生化與分子/生物信息學相關調劑 +5 | 星沉uu 2026-03-26 | 6/300 |
|
|
|
[考研] 打過很多競賽，085406控制工程300分，求調劑 +3 | askeladz 2026-03-26 | 3/150 |
|
|
|
[考研] 334分 一志愿武理-080500 材料求調劑 +4 | 李李不服輸 2026-03-25 | 4/200 |
|
|
|
[考研] 調劑 +4 | 13853210211 2026-03-24 | 4/200 |
|